Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,025 | 72,108 | 66,791 | 81,584 | 122,170 |
| Marketable Securities | 190,992 | 217,781 | 237,819 | 252,408 | 237,603 |
| Receivables | 847 | 970 | 527 | 434 | 679 |
| TOTAL | $260,955 | $294,936 | $309,256 | $339,541 | $364,129 |
| Non-Current Assets | |||||
| PPE Net | 11,392 | 11,461 | 11,864 | 11,735 | 11,236 |
| Intangibles | 29,506 | 29,759 | 30,012 | 30,265 | 30,519 |
| Other Non-Current Assets | 78 | 1,428 | 1,500 | 1,676 | 1,816 |
| TOTAL | $40,976 | $42,648 | $43,376 | $43,676 | $43,571 |
| Total Assets | $301,931 | $337,584 | $352,632 | $383,217 | $407,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,239 | N/A | 2,795 | 2,792 | 2,657 |
| Accounts payable and accrued liabilities | 2,637 | 1,506 | 1,217 | 2,020 | 3,071 |
| Accrued Expenses | 18,431 | 24,316 | 19,623 | 21,879 | 15,420 |
| Other current liabilities | N/A | 4,418 | N/A | N/A | N/A |
| TOTAL | $25,307 | $30,240 | $23,635 | $26,691 | $21,148 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16,592 | 17,239 | 10,370 | 10,648 | 11,000 |
| TOTAL | $16,592 | $17,239 | $10,370 | $10,648 | $11,000 |
| Total Liabilities | $41,899 | $47,479 | $34,005 | $37,339 | $32,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,585 | 6,584 | 6,580 | 6,576 | 6,569 |
| Common Shares | 99 | 99 | 99 | 99 | 98 |
| Retained earnings | -625,629 | -590,956 | -558,272 | -526,292 | -493,933 |
| Other shareholders' equity | 2,687 | 2,307 | 2,560 | 2,436 | 2,616 |
| TOTAL | $260,032 | $290,105 | $318,627 | $345,878 | $375,552 |
| Total Liabilities And Equity | $301,931 | $337,584 | $352,632 | $383,217 | $407,700 |